Company news: Pfizer and PhRMA

Share this article:
Pfizer and Shanghai Pharmaceutical Co. are partnering for a possible Pfizer product launch in China. The companies already co-promote pediatric flu vaccine Prevenar in China.

PhRMA announced its board leadership for the coming year. Sanofi-Aventis CEO Christopher Viehbacher will continue as board chairman of the trade group, while Lilly chief John Lechleiter becomes chairman-elect and Celgene CEO Robert Hugin board treasurer. Viehbacher stepped into the role last year when then-chairman Jeff Kindler abruptly left Pfizer.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.